Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 30%

Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 30%

The “Wegovy” brand slimming syringe is sold in the Achat pharmacy in Mitte. The “Wegovy” slimming syringe has been available in Germany for a year. Jens Kalaene | Picture Alliance | Getty Images Novo Nordisk on Tuesday said it will offer its weight loss drug Wegovy through telehealth providers Hims & Hers Health, Ro and … Read more

Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall

Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall

The Pfizer logo is seen outside the pharmaceutical company’s manufacturing plant, in Newbridge, Ireland February 10, 2025.  Clodagh Kilcoyne | Reuters Pfizer on Tuesday expanded its cost-cutting efforts and reported first-quarter profit that topped estimates, even as the company’s sales fell, largely due to dwindling revenue for its antiviral Covid pill Paxlovid. The company previously … Read more

Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic

Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic

Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy are pictures while the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025.  Mads Claus Rasmussen | Afp | Getty Images Novo Nordisk scored a huge legal victory that … Read more

Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs

Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs

FILE PHOTO: The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Thursday beat first-quarter estimates and hiked its revenue and profit guidance for the year, as the drugmaker cuts costs. The company now expects 2025 … Read more

Merck lowers profit outlook, partly due to $200 million expected tariff hit

Merck lowers profit outlook, partly due to 0 million expected tariff hit

Nurphoto | Nurphoto | Getty Images Merck on Thursday lowered its full-year profit guidance, citing $200 million in estimated costs for tariffs and a charge tied to a recent deal. The company now expects its 2025 adjusted earnings to come in between $8.82 and $8.97, down slightly from a previous outlook of 8.88 to $9.03 … Read more

FDA to phase out dyes used in Flamin’ Hot Cheetos, Skittles and other snacks

FDA to phase out dyes used in Flamin’ Hot Cheetos, Skittles and other snacks

Candy is displayed for sale, as U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., along with FDA Commissioner Marty Makary, announce the FDA’s intent to remove from the U.S. food supply “petroleum-based synthetic” food dyes, which are present in numerous foods such as breakfast cereals, candy, snacks, and beverages, at a grocery … Read more

UnitedHealth’s stock is plunging on higher medical costs. That may mean trouble for more insurers

UnitedHealth’s stock is plunging on higher medical costs. That may mean trouble for more insurers

The logo of UnitedHealth appears on the side of one of its office buildings in Santa Ana, California, on April 13, 2020. Mike Blake | Reuters UnitedHealth Group‘s stock sank 20% on Thursday after the company slashed its annual profit forecast, citing higher-than-expected medical costs in its privately run Medicare plans.  Those bleak results from … Read more

Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients

Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients

Eli Lilly on Thursday said its daily obesity pill met the company’s goals in the first of several late-stage trials, helping patients with Type 2 diabetes lower their blood sugar and body weight and showing safety comparable with popular injections on the market.  The trial results are among the pharmaceutical industry’s most closely watched studies … Read more

Pfizer scraps daily weight loss pill after liver injury in one patient

Pfizer scraps daily weight loss pill after liver injury in one patient

Kena Betancur | Corbis News | Getty Images Pfizer on Monday said it would end development of its experimental daily weight loss pill after a patient experienced a liver injury that was potentially caused by the drug in a trial.  The patient did not experience any liver-related symptoms or side effects, a Pfizer spokesperson said … Read more

Trump’s pharmaceutical tariffs could raise costs for patients, worsen drug shortages

Trump’s pharmaceutical tariffs could raise costs for patients, worsen drug shortages

A pharmacist collects medications for prescriptions at a pharmacy. Simon Dawson | Bloomberg | Getty Images President Donald Trump’s planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences for drugmakers and American patients, some experts told CNBC.  The duties could disrupt the complex pharmaceutical supply chain, drive up the prices of drugs … Read more